US 7,556,942 B2
	Tumor suppressor designated Hippo
Duojia Pan, Baltimore, Md. (US)
Assigned to Board of Regents, The University of Texas System, Austin, Tex. (US)
Filed on Jul. 15, 2004, as Appl. No. 10/892,544.
Claims priority of provisional application 60/487511, filed on Jul. 15, 2003.
Prior Publication US 2005/0053592 A1, Mar. 10, 2005
Int. Cl. C12P 21/04 (2006.01); C12P 21/06 (2006.01)

U.S. Cl. 435—70.1  [435/69.1]

8 Claims

1. A primary tumor cancer cell comprising an expression cassette comprising a polynucleotide encoding a polypeptide having the sequence of SEQ ID NO:2, wherein said polynucleotide is under the control of a promoter operable in eukaryotic cells, said promoter being heterologous to said polynucleotide.